Question to the Department of Health and Social Care:

To ask Her Majesty's Government what recent discussions they have had with (1) the Medicines and Healthcare products Regulatory Agency, and (2) the National Institute for Health and Care Research, about which lessons from the success of COVID-19 trials could be applied to improve the (a) approval, and (b) set-up process, for dementia trials.

This question was answered on 28th April 2022
It has not proved possible to respond to this question in the time available before Prorogation. Ministers will correspond directly with the Member.